by Filewod, N.C. et al.
Department of Microbiology and Immunology, Centre for Microbial Diseases and Immunity Research, University of British Columbia, Lower Mall Research Station
Department of Microbiology and Immunology, Centre for Microbial Diseases and Immunity Research, University of British Columbia, Lower Mall Research Station
In combination with the TLR2/1 agonist PAM3CSK4, LL-37 synergistically induced transcription and the release of both IL-8 and IL-6 from primary bronchial epithelial cells; the IL-8 response was demonstrated to be regulated by epidermal growth factor receptor signalling.
FEMS Immunol. Med. Microbiol. 2009; 3:233-40
